Cognex Corporation (NASDAQ:CGNX) Receives $57.00 Average Price Target from Brokerages

Shares of Cognex Corporation (NASDAQ:CGNXGet Free Report) have been assigned a consensus rating of “Moderate Buy” from the sixteen analysts that are presently covering the company, Marketbeat reports. Six research analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $57.00.

Several equities research analysts recently commented on the company. Robert W. Baird set a $55.00 price objective on Cognex in a research report on Tuesday, February 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $63.00 price objective on shares of Cognex in a research report on Friday, February 13th. Truist Financial dropped their price objective on Cognex from $45.00 to $42.00 and set a “hold” rating on the stock in a research report on Thursday, December 18th. DA Davidson set a $55.00 price objective on Cognex and gave the company a “neutral” rating in a research report on Tuesday, February 17th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $70.00 price objective (up from $50.00) on shares of Cognex in a research report on Friday, February 13th.

View Our Latest Stock Report on CGNX

Insider Buying and Selling at Cognex

In other Cognex news, Director Angelos Papadimitriou sold 4,150 shares of the stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $55.58, for a total value of $230,657.00. Following the transaction, the director owned 16,222 shares of the company’s stock, valued at approximately $901,618.76. This represents a 20.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert Willett sold 177,052 shares of the stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $58.39, for a total value of $10,338,066.28. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 196,083 shares of company stock valued at $11,419,321. 1.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Quent Capital LLC bought a new position in Cognex in the third quarter valued at about $26,000. REAP Financial Group LLC bought a new position in Cognex in the third quarter valued at about $27,000. Geneos Wealth Management Inc. lifted its holdings in Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 736 shares during the period. CIBC Private Wealth Group LLC lifted its holdings in Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after acquiring an additional 327 shares during the period. Finally, First Horizon Corp bought a new position in Cognex in the third quarter valued at about $38,000. Institutional investors own 88.12% of the company’s stock.

Cognex Price Performance

Cognex stock opened at $49.52 on Friday. Cognex has a one year low of $22.67 and a one year high of $59.88. The stock has a market capitalization of $8.27 billion, a PE ratio of 73.91 and a beta of 1.47. The business’s fifty day moving average is $49.51 and its 200 day moving average is $43.75.

Cognex (NASDAQ:CGNXGet Free Report) last released its quarterly earnings data on Wednesday, February 11th. The scientific and technical instruments company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. Cognex had a return on equity of 9.02% and a net margin of 11.51%.The company had revenue of $252.34 million for the quarter, compared to analysts’ expectations of $238.92 million. During the same period last year, the firm posted $0.16 earnings per share. Cognex’s revenue was up 9.9% compared to the same quarter last year. As a group, sell-side analysts expect that Cognex will post 0.61 EPS for the current fiscal year.

Cognex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 12th. Shareholders of record on Thursday, February 26th were issued a $0.085 dividend. The ex-dividend date of this dividend was Thursday, February 26th. This represents a $0.34 dividend on an annualized basis and a yield of 0.7%. Cognex’s dividend payout ratio is currently 50.75%.

Cognex Company Profile

(Get Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Read More

Analyst Recommendations for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.